Drug Research

Proteostasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for PTI-428, the Company’s cystic fibrosis transmembrane…
Read More...

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research…
Read More...

The American Society for Radiation Oncology declared a new clinical guideline for the usage of whole breast radiation therapy for breast Cancer augmenting the population of patients…
Read More...

Merriimack Pharmaceuticals which is a clinical-stage oncology company focused on biomarker-defined cancers asserted that it is augmenting enrollment in the ongoing randomized Phase 2…
Read More...

BioVentrix announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial. The trial is designed to demonstrate the…
Read More...

Check-Cap which is a clinical-stage medical diagnostics company engaged in the development of C-Scan which is an ingestible capsule for preparation-free, colorectal cancer screening,…
Read More...

Cadent Therapeutics which is a precision neuroscience company developing novel medicines to restore movement and cognitive function in patients with neurological and psychiatric disease…
Read More...

Cantex Pharmaceuticals which is a clinical stage  bio-pharmaceutical company developing proprietary pharmaceuticals that enhance the treatment of cancers and other fatal disorders…
Read More...

Autonomic Technologies asserted that the College of the French National Authority for Health issued a optimistic opinion on Forfait Innovation package for the Pulsante SPG…
Read More...

MYR Pharma GmbH asserted the completion of MYR 202 Clinical Trial which is a Phase 2b study investigating Myrcludex B in chronic hepatitis Delta patients which is a more acute form of…
Read More...

When compared to medical therapies, a bariatric surgeon and an endocrinologist specializing in diabetes observed that the effectiveness of medical versus surgical intervention proved to…
Read More...

Intec Pharma asserted that it has partnered with LTS Lohmann Therapie-Systeme AG for manufacturing Company's lead candidate, Accordion Pill Carbidopa/Levodopa (AP-CD/LD) as a treatment…
Read More...

As far as an article published in Experimental Biology and Medicine is concerned, Experimental Biology and Medicine ascertains a new pathway that contributes to lung failure in patients…
Read More...

Paramount comprehensive liquid biopsy, Guardant360 assay to be utilized as sole liquid biopsy in LC-SCRUM-Japan which is a nationwide genomic screening network run by the National…
Read More...

MiNA Therapeutics announced the publication of pre-clinical data on its MTL-CEBPA program in which the compound was shown to promote disease reversal in several models of liver disease…
Read More...

Pfizer declared optimistic outcome from U.S FDA's Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.  The  GIDAC met to discuss Pfizer’s supplemental New Drug Application (sNDA…
Read More...

In a bid to expand its premium Cardiovascular ultrasound system that delivers a complete solution for structural heart analysis, Canon Medical Systems USA has introduced a new version…
Read More...

MiMedx Group which is a leading developer and marketer of regenerative and therapeutic biologics asserted that the U.S Food and Drug Administration has extended MiMedx's micronized…
Read More...

CTI BioPharma Corp asserted that results from the Phase 3 PERSIST-2 clinical Trial of pacritinib which is an investigational JAK22 inhibitor that has been published online in JAMA…
Read More...

FDA approved the conduct of a pivotal Clinical Trial incorporating new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologies, is…
Read More...